OverviewSuggest Edit

Sientra, a medical device company, develops and markets products focusing on the plastic surgery and aesthetics market. Sientra is committed to providing plastic surgeons with intuitive, elegant solutions— as reflected in its innovative round and shaped product lines. It offers breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders.
TypePublic
Founded2007
HQGoleta, CA, US
Websitesientra.com
Employee Ratings3.2
Overall CultureC-

Latest Updates

Employees (est.) (Dec 2019)339(+31%)
Job Openings10
Revenue (FY, 2020)$71.2 M(-14%)
Share Price (Nov 2021)$5.6(-2%)
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Sientra

Ron Menezes

Ron Menezes

Director, President and Chief Executive Officer
Valerie Miller

Valerie Miller

Vice President, Corporate Controller
Deborah Bettencourt

Deborah Bettencourt

Vice President of Human Resources & Corporate Administration
Dan Carlisle

Dan Carlisle

Vice President, Innovation & Product Development, Breast Products
Kirk Gunhus

Kirk Gunhus

Senior Vice President of Worldwide Sales
Oliver Bennett

Oliver Bennett

General Counsel and Chief Compliance Officer
Show more

Sientra Office Locations

Sientra has an office in Goleta
Goleta, CA, US (HQ)
420 S Fairview Ave #200
Show all (1)

Sientra Financials and Metrics

Sientra Revenue

Embed Graph
View revenue for all periods
Sientra's revenue was reported to be $71.24 m in FY, 2020
USD

Revenue (Q1, 2021)

23.2m

Gross profit (Q1, 2021)

12.3m

Gross profit margin (Q1, 2021), %

52.9%

Net income (Q1, 2021)

(54.7m)

EBIT (Q1, 2021)

(9.8m)

Market capitalization (12-Nov-2021)

333.5m

Closing stock price (12-Nov-2021)

5.6

Cash (31-Mar-2021)

80.4m

EV

319.5m
Sientra's current market capitalization is $333.5 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

44.7m38.1m20.7m36.5m68.1m83.7m71.2m

Revenue growth, %

(15%)(46%)

Cost of goods sold

11.5m10.7m6.9m14.2m26.8m33.0m32.3m

Gross profit

33.2m27.5m13.9m22.4m41.3m50.7m38.9m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

10.7m12.4m14.2m9.9m1.5m6.2m6.5m7.5m8.2m9.8m14.7m17.6m16.9m17.6m20.5m22.4m16.9m12.4m23.2m

Cost of goods sold

2.8m3.2m3.9m2.9m760.0k1.7m1.8m2.3m2.6m3.5m6.1m6.7m6.4m6.5m7.8m9.8m6.8m5.6m10.9m

Gross profit

7.8m9.2m10.3m7.0m711.0k4.5m4.7m5.2m5.5m6.3m8.6m10.9m10.5m11.1m12.7m12.7m10.1m6.9m12.3m

Gross profit Margin, %

73%74%72%70%48%72%72%69%68%65%58%62%62%63%62%56%60%55%53%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

96.7m112.8m67.2m26.6m86.9m87.6m55.0m

Accounts Receivable

7.4m8.2m11.8m6.6m22.5m27.5m23.5m

Prepaid Expenses

1.5m2.6m2.5m2.2m

Inventories

1.8m1.5m1.9m20.9m24.1m39.6m48.6m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(5.8m)(41.2m)(40.2m)(64.0m)(82.6m)(106.8m)(89.9m)

Depreciation and Amortization

275.0k318.0k1.2m3.0m3.3m3.5m4.1m

Inventories

1.4m(898.0k)2.4m527.0k(4.2m)(10.9m)(12.8m)

Accounts Payable

(2.3m)1.5m(564.0k)1.3m8.5m(2.2m)(6.4m)
USDQ3, 2014

Debt/Equity

-0.2 x

Debt/Assets

0.4 x

Financial Leverage

-0.5 x
Show all financial metrics

Sientra Cybersecurity Score

Cybersecurity ratingPremium dataset

C

70/100

SecurityScorecard logo

Sientra Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Sientra Online and Social Media Presence

Embed Graph

Sientra Company Culture

  • Overall Culture

    C-

    68/100

  • CEO Rating

    D

    60/100

  • Compensation

    D-

    47/100

Learn more on Comparably

Sientra News and Updates

Sientra Reports Record Breast Products Revenue for Second Quarter 2021, Raises Revenue Guidance for Full Year 2021

SANTA BARBARA, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company exclusively focused on plastic surgery, today announced its financial results for the second quarter ended June 30, 2021.

Sientra Appoints Two Medical Aesthetics Leaders to its Board of Directors

SANTA BARBARA, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the appointment of Dr. Irina Erenburg and Nori Ebersole to its Board of Directors effective July 16…

Sientra Announces Appointment of Chief Financial Officer

SANTA BARBARA, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that Andy Schmidt has been appointed Chief Financial Officer (CFO) effective immediately. As a key …

Sientra Announces Closing of Previously Announced Sale of miraDry Business to 1315 Capital

SANTA BARBARA, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has closed the previously announced sale of its miraDry business to 1315 Capital, a healthcare g…

Sientra Announces Addition of Vice President of Research & Development

SANTA BARBARA, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra" or the “Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced the appointment of Denise Dajles as Vice President of Research & Development, effective today. …

Sientra Announces Sale of miraDry Business to 1315 Capital

Transaction Enables Sharper Focus on Company’s Rapidly Growing Breast Product Business Transaction Enables Sharper Focus on Company’s Rapidly Growing Breast Product Business
Show more

Sientra Frequently Asked Questions

  • When was Sientra founded?

    Sientra was founded in 2007.

  • Who are Sientra key executives?

    Sientra's key executives are Ron Menezes, Valerie Miller and Deborah Bettencourt.

  • How many employees does Sientra have?

    Sientra has 339 employees.

  • What is Sientra revenue?

    Latest Sientra annual revenue is $71.2 m.

  • What is Sientra revenue per employee?

    Latest Sientra revenue per employee is $210.2 k.

  • Who are Sientra competitors?

    Competitors of Sientra include GC Aesthetics, Electromed and StarFish Medical.

  • Where is Sientra headquarters?

    Sientra headquarters is located at 420 S Fairview Ave #200, Goleta.

  • Where are Sientra offices?

    Sientra has an office in Goleta.

  • How many offices does Sientra have?

    Sientra has 1 office.